(19)
(11) EP 2 436 414 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.04.2015 Bulletin 2015/17

(45) Mention of the grant of the patent:
11.03.2015 Bulletin 2015/11

(21) Application number: 11004101.9

(22) Date of filing: 18.05.2011
(51) International Patent Classification (IPC): 
A61M 15/00(2006.01)

(54)

Dose counter for inhalers and inhaler

Dosiszählwerk für Inhalatoren und Inhalator

Compteur de doses pour inhalateurs et inhalateur

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 18.05.2010 US 345763 P
29.11.2010 US 417659 P

(43) Date of publication of application:
04.04.2012 Bulletin 2012/14

(60) Divisional application:
11010209.2 / 2514462
11010210.0 / 2514463
11010211.8 / 2514464
11010212.6 / 2514465
11010213.4 / 2514466
11010214.2 / 2514467
11010215.9 / 2514468
12003933.4 / 2502644

(73) Proprietors:
  • Ivax Pharmaceuticals Ireland
    Waterford (IE)
  • Norton Waterford
    Waterford (IE)
  • TEVA Pharmaceuticals Ireland
    Waterford (IE)

(72) Inventors:
  • Uschold, Robert Charles
    Leominster, MA 01453 (US)
  • Karg, Jeffrey A.
    Hopkinton, MA 01748 (US)
  • Clancy, Paul
    Waterford City (IE)
  • Fenlon, Derek
    Co. Wexford (IE)
  • Walsh, Declan
    Gowran, Co. Kilkenny (IE)
  • Kaar, Simon
    Donoughmore, Co. Cork (IE)
  • Hazenberg, Jan Geert
    Kilkenny, Co. Kilkenny (IE)
  • Buck, Dan
    Annestown, Co. Waterford (IE)

(74) Representative: Cottam, David William 
Teva UK Ltd. Global Patent Group Field House Station Approach
Harlow, Essex CM20 2FB
Harlow, Essex CM20 2FB (GB)


(56) References cited: : 
WO-A1-2005/102430
WO-A1-2008/119552
WO-A1-2011/012327
WO-A2-2008/023019
 WO-A1-2007/012861
WO-A1-2011/012325
WO-A2-02/00281
US-A- 5 482 030
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).